ΠΠ»ΠΈΡΠ½ΠΈΠ΅ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠΎΠ² ΡΠΎΠΏΠΎΠΈΠ·ΠΎΠΌΠ΅ΡΠ°Π·Ρ ΠΈ Π½Π° ΠΏΠ΅ΡΠ΅Ρ ΠΎΠ΄ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΈΠ· ΠΌΠ΅ΡΠ°ΡΠ°Π·Ρ Π² Π°Π½Π°ΡΠ°Π·Ρ ΠΌΠΈΡΠΎΠ·Π°: ΠΠ½Π°Π»ΠΈΠ· ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΡΠΎΡΠΎΡΠ½ΠΎΠΉ ΡΠΈΡΠΎΠΌΠ΅ΡΡΠΈΠΈ
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
ΠΠΈΡΠΎΠ· ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²Π°ΠΆΠ½ΡΡ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² ΠΆΠΈΠ·Π½Π΅Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΊΠ»Π΅ΡΠΊΠΈ, ΡΠ°ΠΊ ΠΊΠ°ΠΊ ΠΎΡ ΠΏΡΠ°Π²ΠΈΠ»ΡΠ½ΠΎΠ³ΠΎ ΠΈ ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠ³ΠΎ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΡ Π²ΡΠ΅Ρ ΡΡΠ»ΠΎΠ²ΠΈΠΉ, Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΡΡ Π΄Π»Ρ Π΅Π³ΠΎ ΠΏΡΠΎΡΠ΅ΠΊΠ°Π½ΠΈΡ ΠΈ Π·Π°Π²Π΅ΡΡΠ΅Π½ΠΈΡ, Π·Π°Π²ΠΈΡΠΈΡ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ°Ρ ΡΡΠ΄ΡΠ±Π° ΠΊΠ»Π΅ΡΠΎΠΊ: ΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΡ Π΄Π°Π»Π΅Π΅ ΠΏΠΎ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΌΡ ΡΠΈΠΊΠ»Ρ ΠΈΠ»ΠΈ ΠΏΠΎΠ΄Π²Π΅ΡΠ³Π½ΡΡΡΡΡ Π°ΠΏΠΎΠΏΡΠΎΠ·Ρ (Ciarke, Gimenez-Abian, 2000). ΠΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ Π΄Π²ΡΡ ΠΎΠ΄ΠΈΠ½Π°ΠΊΠΎΠ²ΡΡ Π΄ΠΎΡΠ΅ΡΠ½ΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊ Π² ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΠΌΠΈΡΠΎΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π΄Π΅Π»Π΅Π½ΠΈΡ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ΅Π½ΠΈΠ½ Π.Π., ΠΠΊΡΠ΅Π½ΠΎΠ² Π.Π, Π¨Π°ΡΡΠΎΠ²Π° Π. Π., ΠΠ»ΠΎΠΏΠΎΠ² Π. Π., ΠΡΠ°ΠΌ Π. Π‘., ΠΠΎΠ»Π΅ΡΠ°Π΅Π² Π. Π. 1999. Π£ΡΡΡΠΎΠΉΡΡΠ²ΠΎ Π΄Π»Ρ ΠΏΡΠ΅Π΄ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΎΠ±ΡΠ°Π·ΡΠ° ΠΏΡΠΈ Π°Π½Π°Π»ΠΈΠ·Π΅ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΡΠΎΡΠΎΡΠ½ΠΎΠΉ ΡΠΈΡΠΎΠΌΠ΅ΡΡΠΈΠΈ. ΠΠΈΠΎΡΠΈΠ·ΠΈΠΊΠ°. 44 (Π²ΡΠΏ.2):303−312.
- ΠΠ΅Π½ΠΈΠ½ Π.Π., ΠΠΊΡΠ΅Π½ΠΎΠ² Π.Π, Π¨Π°ΡΡΠΎΠ²Π° Π. Π., ΠΠ»ΠΎΠΏΠΎΠ² Π. Π., ΠΠΎΠ»Π΅ΡΠ°Π΅Π² Π. Π. 1998. Π€Π»ΡΠΎΡΠΈΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· Π² ΠΏΠΎΡΠΎΠΊΠ΅ Ρ ΡΠΎΠΌΠΎΡΠΎΠΌΠ½ΡΡ Π½Π°Π±ΠΎΡΠΎΠ² ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ Π²ΠΎΡΡΠΌΠΎΠΉ Π²ΡΠ΅ΡΠΎΡΠ·Π½ΠΎΠΉ ΠΈΡΠΎΠ³ΠΎΠ²ΠΎΠΉ ΠΊΠΎΠ½ΡΠ΅ΡΠ΅Π½ΡΠΈΠΈ «ΠΠ΅Π½ΠΎΠΌ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° 98″. ΠΠΎΡΠΊΠ²Π°, Π§Π΅ΡΠ½ΠΎΠ³ΠΎΠ»ΠΎΠ²ΠΊΠ°, Ρ. 37.
- ΠΠ΅Π½ΠΈΠ½ Π.Π., ΠΠ»ΠΎΠΏΠΎΠ² Π. Π., ΠΡΠΎΠ±ΡΠ΅Π½ΠΊΠΎ Π. Π., ΠΠΊΡΠ΅Π½ΠΎΠ² Π. Π., Π¨Π°ΡΡΠΎΠ²Π° Π. Π., ΠΠΎΠ»Π΅ΡΠ°Π΅Π² Π. Π. 2001. ΠΠ½Π°Π»ΠΈΠ· ΠΌΠΈΡΠΎΠ·Π° Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΎΠ΄Π½ΠΎΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΠΎΡΠ»ΡΠΎΡΠΈΠΌΠ΅ΡΡΠΈΠΈ Π² ΠΏΠΎΡΠΎΠΊΠ΅. ΠΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Ρ. 18(3):207−215.
- ΠΡΠ±ΠΈΠ½Π° Π.Π., ΠΡΠ±ΠΈΠ½Π° Π’. Π., ΠΡΠ°ΠΊΠΎΠ²Π° Π. Π., ΠΠΈΠΊΠ½Π°Π΄Π·Π΅ Π. Π. 1994. ΠΠΎΠ»ΠΈΠΏΠ»ΠΎΠΈΠ΄Π½ΡΠ΅ ΠΌΠΈΡΠΎΠ·Ρ Π² ΠΊΠ»Π΅ΡΠΊΠ°Ρ ΡΡΠΎΡΠΎΠ±Π»Π°ΡΡΠ° Π½ΠΎΡΠΊΠΈ. Π¦ΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡ. 36(8):869−873.
- ΠΡΠ½ΠΈΡΠΊΠ°Ρ Π.Π., Π‘ΡΡ ΠΈΡ Π’. Π., ΠΠ°ΠΌΠ°Π΅Π²Π° Π‘. Π. 1998. ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠ° ΠΈ ΡΠ°ΡΡΠΎΡΡ Ρ ΡΠΎΠΌΠΎΡΠΎΠΌΠ½ΡΡ Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΠΉ Π² Π»ΠΈΠΌΡΠΎΡΠΈΡΠ°Ρ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° ΠΏΡΠΈ Π΄Π΅ΠΉΡΡΠ²ΠΈΠΈ ΠΊΠΎΠ»ΡΠ΅ΠΌΠΈΠ΄Π°. Π¦ΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡ. 40(7):682−685.
- ΠΠΈΡ Π°ΡΠ΅Π²Π° Π.Π., ΠΠΎΠ³Π°ΡΠ΅Π² Π‘. Π‘. 2000. ΠΠ΅Π»ΠΊΠΈ Π»Π°ΠΌΠΈΠ½Ρ ΠΈ ΠΈΡ ΡΡΠ½ΠΊΡΠΈΠΈ Π² Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ΅ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠΊΠ»Π°. ΠΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Ρ. 17(5):453−463.
- Π€ΠΎΠ³Π΅Π»Ρ Π€., ΠΠΎΡΡΠ»ΡΡΠΊΠΈ Π. 1989. ΠΠ΅Π½Π΅ΡΠΈΠΊΠ° ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°. Π.:ΠΠΈΡ. 1:308 Ρ.
- Π¨Π°ΡΡΠΎΠ²Π° Π.Π., ΠΠΊΡΠ΅Π½ΠΎΠ² Π. Π., ΠΠ΅Π½ΠΈΠ½ Π. Π. 2001. ΠΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π²Π»ΠΈΡΠ½ΠΈΡ ICRF-193 Π½Π° ΠΏΡΠΎΡ ΠΎΠΆΠ΄Π΅Π½ΠΈΠ΅ ΠΊΠ»Π΅ΡΠΊΠ°ΠΌΠΈ ΠΌΠΈΡΠΎΠ·Π° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠΈΡΠΎΠΌΠ΅ΡΡΠΈΠΈ Π² ΠΏΠΎΡΠΎΠΊΠ΅. ΠΠ΅ΠΆΠ΄ΡΠ½Π°ΡΠΎΠ΄Π½ΡΠΉ ΡΠΈΠΌΠΏΠΎΠ·ΠΈΡΠΌ „ΠΠΈΠΎΠ»ΠΎΠ³ΠΈΡ ΠΊΠ»Π΅ΡΠΊΠΈ Π² ΠΊΡΠ»ΡΡΡΡΠ΅“, Π‘Π°Π½ΠΊΡ-ΠΠ΅ΡΠ΅ΡΠ±ΡΡΠ³, Π¦ΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡ. 43:902−903.
- Π¨Π°ΡΡΠΎΠ²Π° Π.Π., ΠΠΊΡΡΠ½ΠΎΠ² Π. Π., ΠΠ΅Π½ΠΈΠ½ Π. Π., ΠΠΎΠ»Π΅ΡΠ°Π΅Π² Π. Π. 1996. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ Π»ΠΈΠ·ΠΎΠ»Π΅ΡΠΈΡΠΈΠ½Π° Π΄Π»Ρ ΠΏΠΎΠ»ΡΡΠ΅Π½ΠΈΡ Ρ ΡΠΎΠΌΠΎΡΠΎΠΌ. Π¦ΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡ. 38(1):95−101.
- Π¨Π°ΡΡΠΎΠ²Π° Π.Π., ΠΠΊΡΡΠ½ΠΎΠ² Π. Π., Π’Π΅ΡΠ»Π΅Π½ΠΊΠΎ J1.Π., ΠΠ΅Π½ΠΈΠ½ Π. Π. 1994. Π€ΡΠ°ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Ρ ΡΠΎΠΌΠΎΡΠΎΠΌ Π² Π³ΡΠ°Π΄ΠΈΠ΅Π½ΡΠ΅ ΠΏΠ»ΠΎΡΠ½ΠΎΡΡΠΈ ΡΠ°Ρ Π°ΡΠΎΠ·Ρ Π΄Π»Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ΅ΠΉ ΠΏΡΠΎΡΠΎΡΠ½ΠΎΠΉ ΡΠΎΡΡΠΈΡΠΎΠ²ΠΊΠΈ. Π¦ΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡ. 36(7):708−712.
- Π―ΠΊΡΠ±ΠΎΠ²ΡΠΊΠ°Ρ Π.Π., ΠΠ°Π±ΠΈΠ±ΠΎΠ² Π. Π. 1999. Π’ΠΎΠΏΠΎΠΈΠ·ΠΎΠΌΠ΅ΡΠ°Π·Ρ. ΠΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΡ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΠΎΠΏΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΠΠ. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ. 33 (3):368−384.
- Anderson H.J., de Jong G., Vincent I., Roberge M. 1998. Flow cytometry of mitotic cells. Exp. Cell Res. 238:498−502.
- Andoh Π’., Ishida R. 1998. Catalytic inhibitors of DNA topoisomerase II. Biochem. biophys. acta. 1400:155−171.
- Andreassen P.R., Margolis R.L. 1991. Induction of partial mitosis in BHK cells by 2-aminopurine. J. Cell Sci. 100:299−310.
- Andreassen P.R., Margolis R.L. 1992. 2-aminopurine overrides multiple cell cycle checkpoints in BHK cells. Proc. Natl. Acad. Sci. U.S.A. 89:2272−2276.
- Andreassen P.R., Martineau S.N., Margolis R.L. 1996. Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state. Mutat. Res. 372:181−194.
- Ardito G., Lamberti L., Brogger A. 1978. Satellite associations of human acrocentric chromosomes identified by treatment at metaphase. Ann. Hum. Genet. 41:455−462.
- Ashley T. 1979. Specific end to end attachment of chromosomes in Ornithogalum virens. J. Cell. Sci. 38:357−367.
- Austin C.A., Marsh K.L. 1998. Eukaryotic DNA topoisomerase II p. BioEssays. 20:215−226.
- Barbiero G., Duranti F., Bonelli G., Amenta J.S., Baccino F.M. 1995. Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. Exp. Cell Res. 217:410−418.
- Berger J.M. 1998. Structure of DNA topoisomerases. Biochem. Biophys. acta. 1400:3−18.
- Blasina A., Price B.D., Turenne G.A. 1999. Caffeine inhibits the checkpoint kinase ATM. Curr. Biol. 9:1135−1138.
- Bojanowski K., Maniotis A.J., Plisov S., Larsen A.K., Ingber D.E. 1998. DNA Topoisomerase II can drive changes in higher order chromosome architecture without enzymatically modifying DNA. J.Cell.Biochem. 69:127−142.
- Burden D.N., Osheroff N. 1998. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochem. Biophys. acta. 1400:139−154.
- Burke B. 1990. On the cell-free association of lamins A and C with metaphase chromosomes. Exp. Cell Res. 186:169−76.
- Charron M., Hancock R. 1991. Chromosome recombination and defective genome segregation induced in Chinese hamster cells by the topoisomerase II inhibitor VM-26. Chromosoma. 100:97−102.
- Chen M, Beck W.T. 1995. Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26. Cancer Res. 55:1509−1516.
- Christensen M.O., Larsen M.K., Barthelmes H.U., Hock R., Andersen C.L., Kjeldsen E., Knudsen B.R., Westergaard O., Boege F., Mielke C. 2002. Dynamics of human DNA topoisomerases II a and II |3 in living cells. J. Cell Biol. 157:31−44.
- Cimini D., Antoccia A., Tanzarella C., Degrassi F. 1997. Topoisomerase II inhibition in mitosis produces numerical and structural chromosomal aberrations in human fibroblasts. Cytogenet. Cell Genet. 76:61−67.
- Clarke D.J., Gimenez-Abaian J.F. 2000. Checkpoints controlling mitosis. BioEssays. 22:351−363.
- Clarke D.J., Johnson R.T., Downes C.S. 1993. Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks. J. Cell Sci. 105:563−569.
- Deming P.B., Cistulli C.A., Zhao H., Graves P.R., Piwnica-Worms H., Paules R.S., Downes C.S., Laufmann W.K. 2001. The human decatenation checkpoint. Proc. Natl. Acad. Sci. U.S.A. 98:12 044−12 049.
- Deplanque G., Vincent F., Mah-Becherel M.C.M., Cazenave J-P, Bergerat J-P., Klein-Soyer C. 2000. Caffeine does not cause override of the G2/M blockinduced by UV or gamma radiation in normal human skin fibroblasts. British J. of Cancer. 83:346−353.
- Diffley J.F.X., Evan G. 2000. Oncogenes and cell proliferation. Cell cycle, genome integrity and cancer-a millennial view. Curr. Opin. Genet. Dev. 10:1316.
- Dolbeare F., Gratzner H., Pallavinci M.G., Gray J.W. 1983. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA. 80:5573−5577.
- Downes C.S., Clarke D.J., Mullinger A.M., Gimenez-Abian J.F., Creighton A.M., Johnson R.T. 1994. A topoisomerase ll-dependent G2 cycle checkpoint in mammalian cells. Nature. 372:467−470.
- Downes C.S., Mullinger A.M., Jonson R.T. 1991. Inhibitors of topoisomerase II prevent chromatid separation in mammalian cells, but do not prevent exit from mitosis. Proc. Natl. Acad. Sci. USA 88:8895−8899.
- DuPraw E.J. 1966. Evidence for a „folded-fiber“ organization in human chromosomes. Nature (Lond.) 209:577−581.
- Earnshaw W.C., Halligan B, Cooke C.A., Heck M.M.S., Lin L.F. 1985. Topoisomerase II is a structural component of mitotic chromosome scaffold. J. Cell Biol. 100:1706−1715.
- Earnshaw W.C., Heck M.M.S. 1985. Localisation of topoisomerase II in mitotic chromosomes. J. Cell Biol. 100:1716−1725.
- Edgar B.A., Orr-Weaver T.L. 2001. Endoreplication Cell Cycles: More for Less. Cell. 105:297−306.van den Engh G., Trask B., Cram S., Bartholdi M. 1984. Preparation of chromosome suspensions for flow cytometry. Cytometry. 5:108−117.
- Erenpreisa J., Cragg M.S., 2001. Mitotic death: a mechanism of survival? Cancer Cell Int. 1:1 (http://www.cancerci.c0m/c0ntent/l/l/l).
- Giaretti W., Nusse M., Bruno S., Di Vinci A., Giedo E. 1989. A new method to discriminate Gi, S, G2, M, and Gi postmitotic cells. Exp. Cell Res. 182:290 295.
- Gimenez-Abian J.F., Clarke D. J, Devlin J., Gimenez-Abian M.I., De la Torre C., Johnson R.T., Mullinger A.M., Downes C.S. 2000. Premitotic chromosome individualization in mammalian cells depends on topoisomerase II activity. Chromosoma. 109:235−244.
- Gong J., Traganos F., Darzynkiewicz Z. 1993. Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements. Cancer Res. 53:5096−5099.
- Gong J., Traganos F., Darzynkiewicz Z. 1995. Discrimination of G2 and mitotic cells by flow cytometry based on different expression of cyclins A and B1. Exp. Ceil Res. 220:226−231.
- Grue P., GralSer A., Sehested M., Jensen P.B., Uhse A., Straub T., Ness W., Boege F. 1998. Essential mitotic functions of DNA topoisomerase Hot are not adopted by topoisomerase lip in human H69 cells. J.Biol.Chem. 273:3 366 033 666.
- Hallowes R.C., West D.G., Hellmann K. 1974. Cumulative cytostatic effect of ICRF-159. Nature. 247:487−491.
- Hande K.R. 1998. Clinical applications of anticancer drugs targeted to topoisomerase II. Biochem. biophys. acta. 1400:173−184.
- Hens I., Kirsch-Volders M., Verschaeve L., Susanne C. 1982 The central localization of the small and early replicating chromosomes in human diploid metaphase figures. Hum. Genet. 60:249−256.
- Hernandez-Verdun D., Gautier T. 1994. The Chromosome Periphery. BioEssays. 16:179−185.
- Hossain M.S., Akimitsu N., Takaki T» Hirai H., Sekimizu K. 2002. ICRF-193, a catalytic inhibitor of DNA topoisomerase II, inhibits re-entry into the cell division cycle from quiescent state in mammalian cells. Genes Cells. 7:285−294.
- Jensen L.H., Nitiss K.C., Rose A., Dong J., Zhou J., Hu T., Osheroff N., Jensen P.B., Sehested M., and Nitiss J.L. 2000. A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines. J. Biol. Chem. 275:21 372 146.
- Jaroszeski M.J., Radcliff G. 1999. Fudamentals of flow cytometry. Mol. Biotechnol. 11:37−53.
- Juan G., Traganos F., Darzynkiewiez Z. 2001. Methods to identify mitotic cells by flow cytometry. Methods Cell Biol. 63:343−354.
- Kaufmann S.H. 1998. Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochem. biophys. acta. 1400:195−211.
- Kaufmann W.K., Kies P.E. 1998. DNA signals for G2 checkpoint response in diploid human fibroblasts. Mutat. Res. 400:153−167.
- Kingma P. S., Osheroff N., 1998. Apurinic sites are position-specific topoisomerase ll-poisons. J. Biol. Chem. 272:1148−1155.
- Kingma P. S., Osheroff N., 1998. Spontaneous DNA damage stimulates topoisomerase ll-mediated DNA cleavage. J. Biol. Chem. 272:7488−7493.
- Kirsch-Volders M., Cundari E., Verdoodt B. 1998. Towards a unifying model for the metaphase/anaphase transition. Mutagenesis. 13:321−335.
- Korf B.R., Diacumakos E.G. 1977. Random arrangement of mitotic chromosomes in radial metaphases of Indian muntjac. Cytogenet. Cell Genet. 19:335−343.
- Korf B.R., Diacumakos E.G. 1978. Microsurgically-extracted metaphase chromosomes of the Indian muntjac examined with phase contrast and scanning electron microscopy. Exp. Cell Res. 111:83−93.
- Maniotis A.J., Bojanowski K, Ingber D.E. 1997. Mechanical continuity and reversible chromosome disassembly within intact genomes removed from living cells. J. Cell. Biochem. 65:114−130.
- Molinari M. 2000. Cell cycle checkpoints and their inactivation in human cancer. Cell prolif. 33:261−274.
- Morrist S.K., Baird C.L., Lindsley J. 2000. Steady state and rapid kinetic analysis of topoisomerase II trapped as the closed-clamp intermediate by ICRF-193. J. Biol. Chem. 275:2613−2618.
- Mosgoller W., Leitch A.R., Brown J.K., Heslop-Harrison J.S. 1991. Chromosome arrangements in human fibroblasts at mitosis. Hum. Genet. 88:27−33.
- Munoz P., Baus F., Piette J. 2001. Ku antigen is required to relieve G2 arrest caused by inhibition of DNA topoisomerase II activity by the bisdioxopiperazine ICRF-193. Oncogene. 20:1990−1999.
- Myhra S, Brogger A. 1975. Interchromosomal DNA-containing fibers in human cells. Humangenetik. 29:183−189.
- Nagele R., Freeman T., Fazekas J., Lee K.M., Thomson Z., Lee H.Y. 1998. Chromosome spatial order in human cells: evidence foe early origin and faithful propagation. Chromosoma. 107:330−338.
- Nagele R., Freeman T., McMorrow L., lee H.Y. 1995. Precise spatial positioning of chromosomes during prometaphase: evidence for chromosomal order. Science. 270:1831−1835.
- Nasmyth K., Peters J.M., Uhlmann F. 2000. Splitting the chromosome: cutting the ties that bind sister chromatids. Science. 288:1379−1384.
- Nitiss J.L. 1998. Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochem. biophys. acta. 1400:63−81.
- Nitiss J.L., Lin Y.X., Harbury P., Jannatipour M., Wasserman R., Wang J.C. 1992. Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase II. Cancer Res. 52:4467−4472.
- Nusse M, Julch M., Geido E., Bruno S., Di Vinci A., Giaretti W., Ruoss K. 1989. Flow cytometric detection of mitotic cells using the bromodeoxyuridine/DNA technique in combination with 90 degrees and forward scatter measurements. Cytometry. 10: 312−319.
- Nusse M., Beisker W., Hoffman C., Tamok A. 1990. Flow cytometric analysis of Gi- and G2/M-phase subpopulations in mammalian cell nuclei using side scatter and DNA content measurements. Cytometry 11:813−821.
- Parry D.H., O’Farrell P.H., 2001. The shedule of destruction of three mitotic cyclins can dictate the timing of events during exit from mitosis. Curr. Biol. 11:671−683.
- Patel S., Jazrawi E., Creighton A.M., Austin C.A., Fisher L.M. 2000. probing the interaction of the cytoxic bisdioxopiperazine ICRF-193 with the closed clamp of human topoisomerase II a. Mol. Pharmacol. 58:560−568.
- Perez C., Pelayo F., Vilaboa N.E., Aller P. 1994. Caffeine attenuates the action of amsacrine and etoposide in U-937 cells by mechanisms which involve inhibition of RNA synthesis. Int. J. Cancer. 57:889−893.
- Pines J., Rieder C.L. 2001. Re-staging mitosis: a contemporary view of mitotic progression. Nature Cell Biol. 3: E3-E6 (http://cellbio.nature.com).
- Poljak L., Kas E. 1995. Resolving the role of topoisomerase II in chromatin structure and function. Trends Cell Biol. 5:348−354.
- Powell S.N., DeFrank J.S., Connel P., Eogan M., Preffer F., Dombkowski D., Tang W., Friend S. 1995. Differential sensitivity of p53H and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 55:1643−1648.
- Rieder C.L., Cole R.W. 1998. Entry into mitosis in vertebrate somatic cells is guarded by a chromosome damage checkpoint that reverses the cell cycle when triggered during early but not late prophase. J. Cell Biol. 142:1013−1022.
- Runder A.D., Murray A.W. 1996. The spindle assembly checkpoint. Curr. Opin. Cell Biol. 8:773−780.
- Sarkaria J.N., Eshleman J.S. 2001. ATM as a target for novel radiosensitizers. Semin. Radiat. Onkol. 11:316−327.
- Sato M" Ishida R" Ohsumi K" Narita T" Andoh T. 1997. DNA topoisomerase II as the cellular target of a novel antitumor agent ICRF-193, abisdioxopiperazine derivative, in Xenopus egg exstract. Biochem. Biophys. Res. Commun. 235:571−575.
- Sharp H.B.A., Field E.O., Hellmann K. 1970. Mode of action of the cytostatic effect of 'ICRF-159'. Nature. 226:524−526.
- Simili M., Pellerano P., Pigullo S., Tavosanis G., Ottaggio L., de Saint-Georges L., Bonatti S. 1997. 6DMAP inhibition of early cell cycle events and induction of mitotic abnormalities. Mutagenesis. 12:313−319.
- Smits V.A.J., Medema R.H. 2001. Checking out the G2/M transition. Biochim. biophys. acta. 1519:1−12.
- Sramkoski R.M., Wormsley S.W., Bolton W.E., Crumpler D.C., Jacobberger J.W. 1999. Simultaneous detection of cyclin B1, p105, and DNA content provides complete cell cycle phase fraction analysis of cells that endoreduplicate. Cytometry. 35:274−283.
- Sugimoto K., Yamada K., Egashira M., Yazaki Y., Hirai H., Kikuchi A., Oshimi K. 1998. Temporal and spatial distribution of DNA topoisomerase II alters during proliferation, differentiation, and apoptosis in HL-60 cells. Blood. 91:1407−1417.
- Sumner A.T. 1992. Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis. J. Cell Sci. 103:105−115.
- Sumner A.T. 1995. Inhibitors of topoisomerase II progress through mitosis and induce a doubling of the DNA content in CHO cells. Exp. Cell Res. 217:440−447.
- Sumner A.T. 1996. The distribution of topoisomerase II on mammalian chromosomes. Chromosoma Res. 4:5−14.
- Sumner A.T. 1998. Induction of diplochromosomes in mammalian cells by inhibitors of topoisomerase II. Chromosoma 107:486−490.
- Sun H. B, Yokota H. 1999. Correlated positioning of homologous chromosomes in daughter fibroblast cells. Chromosome. Res. 7:603−610.
- Takahashi M. 1996. A Fractal-like Geometry of the Nucleus and its reproduction: A Hypothesis. A Genomic Theory of the Tumor Cell Cycle. Ube. Japan. 1:265 p.
- Tanabe K., Ishida R., Andoh T. 1991. Inhibition of topoisomerase II by antitumor agents bis (2,6-dioxopiperazine) derivatives. Cancer Res. 51: 49 034 908.
- Van Hooser A., Goodrich D.W., Allis C.D., Brinkley B.R., Mancini M.A. 1998. Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation. J. Cell Sci. 111:3497−3506.
- Verdoodt B., Decordier I., Geleyns K., Cunha M., Cundari E., Kirsch-Volders M. 1999. Induction of polyploidy and apoptosis after exposure to high concentrations of the spindle poison nocodazole. Mutagenesis. 14:513−520.
- Wang S., Norbury C., Harris A.L., Toda T. 1999. Caffeine can override the S-M checkpoint in fission yeast. J. Cell Sci. 112:927−937.
- Webb C D., Latham M.D., Lock R.B., Sullivan D.M. 1991. Attenuated topoisomerase II content directly correlated with a low level of drug resistance in a Chinese hamster ovary cell line. Cancer Res. 51 -.6543−6549.
- Widrow R.J., Laird C.D. 2000. Enrichment for submitotic cell populations using flow cytometry. Cytometry. 39:126−130.
- Wollenberg C., Kiefaber M.P., Zang K.D. 1982. Quantitative studies on the arragement of human metaphase chromosomes. IX. Arrangement of chromosomes with and without spindle apparatus. Hum. Genet. 62:310−315.
- Zechiedrich EL, Osheroff N. 1990. Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossovers. EMBO J. 9:4555−62.
- Zieve G. W, Turnbull D., Mullins J.M., Mcintosh J.R. Z. 1980. Production of large numbers of mitotic mammalian cells by use of the reversible microtubule inhibitor nocodazole. Exp. Cell Res. 126:397−405.
- Zucker R.M., Elstein K.H., Easterling R.A., Massaro E.J. 1988. Flow cytometric discrimination of mitotic nuclei by right-angle scatter. Cytometry. 9:226−231.